Visalytics
Visalytics
approved EB-2 (NIW)

Assistant Professor

Pharmaceutical Science · Bangladesh · 2025-07-12

Processing Time
549 days
Decision Date
2025-07-12
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to advance pharmaceutical science through the development and validation of UV-spectroscopic assays for drug potency and purity. Her work focuses on probing drug-protein interactions to enhance predictive models of efficacy and investigating the phytochemical composition of plant extracts for anti-inflammatory and antimicrobial therapeutics.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses public-health needs by ensuring patient safety and reducing the economic burden of drug recalls.

2 Well-positioned to Advance the Endeavor Met

The petitioner's academic background, industry experience, and publication record demonstrate her capacity to drive innovation in drug safety.

3 Balance of Interests Met

The petitioner's unique expertise in analytical chemistry and regulatory compliance makes her contributions sufficiently beneficial to waive the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's 26 total publications (24 peer-reviewed) and 133 citations, demonstrating widespread adoption of her methodologies. Evidence included her Ph.D. in pharmaceutical chemistry and invitations to serve as a peer reviewer for leading journals. All three Dhanasar prongs were satisfied through a combination of quantitative metrics and expert testimonials.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Reference Letters Dependent
Judging Experience
Original Contributions

Similar Cases

Others

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
Michigan 469 days 2025-02-20
The petitioner proposes to advance analytical techniques crucial for monitoring pharmaceutical quality across drug discovery, manufacturing, and clinical evaluation stages. Her work focuses on developing and optimizing analytical methods to ensure the safety, consistency, and potency of treatments for cancer and chronic conditions. This endeavor aims to improve medication validation processes and enhance the reliability of drug quality assurance.
View Case

Postdoctoral Researcher

Pharmaceuticals · Vietnam

WeGreened EB-2 (NIW) approved
278 days 2025-01-11
The petitioner proposes to identify and analyze novel bioactive compounds isolated from natural sources with distinct chemical diversity. This work aims to accelerate the development of new pharmaceuticals for chronic diseases that currently lack adequate treatments, such as diabetes, cardiovascular disease, and osteoporosis.
View Case

Others

Pharmaceuticals · Iran

WeGreened EB-2 (NIW) approved
598 days 2025-09-08
The petitioner proposes to advance drug discovery by designing and improving in-vitro testing methodologies to enhance precision and streamline timelines in pre-clinical research. Her work focuses on creating standardized approaches for toxin assessment to reduce the reliance on animal testing and lower the high failure rates of clinical trials.
View Case

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
Wisconsin 94 days 2025-01-29
The petitioner proposes to investigate the design, synthesis, optimization, and characterization of small molecule compounds. This work focuses on developing therapeutic agents to address drug-resistant infections and improve medication safety and efficacy.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from Bangladesh

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-07-12.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 549 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,814
Success Rate 53.6%
Sustained 2,046
Dismissed 1,672

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Bangladesh All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist